Literature DB >> 23458664

Metal stents: a bridge to surgery in hilar cholangiocarcinoma.

Dirk J Grünhagen1, Declan F J Dunne, Richard P Sturgess, Nick Stern, Stephen Hood, Stephen W Fenwick, Graeme J Poston, Hassan Z Malik.   

Abstract

BACKGROUND: Obstructive jaundice in patients with hilar cholangiocarcinoma is a known risk factor for hepatic failure after liver resection. Plastic stents are most widely used for preoperative drainage. However, plastic stents are known to have limited patency time and therefore, in palliative settings, the self-expanding metal stent (SEMS) is used. This type of stent has been shown to be superior because it allows for rapid biliary decompression and a reduced complication rate after insertion. This study explores the use of the SEMS for biliary decompression in patients with operable hilar cholangiocarcinoma.
METHODS: A retrospective evaluation of a prospectively maintained database at a tertiary hepatobiliary referral centre was carried out. All patients with resectable cholangiocarcinoma were recorded.
RESULTS: Of 260 patients referred to this unit with cholangiocarcinoma between January 2008 and April 2012, 50 patients presented with operable cholangiocarcinoma and 27 of these had obstructive jaundice requiring stenting. Ten patients were initially treated with SEMSs; no stent failure occurred in these patients. Seventeen patients initially received plastic stents, seven of which failed in the interval between stent placement and laparotomy. These stents were replaced by SEMSs in four patients and by plastic stents in three patients. Median time to laparotomy was 45 days and 68 days in patients with SEMSs and plastic stents, respectively.
CONCLUSIONS: Self-expanding metal stents provide adequate and rapid biliary drainage in patients with obstruction caused by hilar cholangiocarcinoma. No re-interventions were required. This probably reflects the relatively short interval between stent placement and laparotomy.
© 2012 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23458664      PMCID: PMC3633039          DOI: 10.1111/j.1477-2574.2012.00588.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  37 in total

Review 1.  Pancreatic cancer.

Authors:  Manuel Hidalgo
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

2.  Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study.

Authors:  Birgit Gruenberger; Johannes Schueller; Ute Heubrandtner; Fritz Wrba; Dietmar Tamandl; Klaus Kaczirek; Rudolf Roka; Sandra Freimann-Pircher; Thomas Gruenberger
Journal:  Lancet Oncol       Date:  2010-11-09       Impact factor: 41.316

Review 3.  Preoperative biliary drainage for obstructive jaundice.

Authors:  Qin Wang; Kurinchi Selvan Gurusamy; He Lin; Xiaodong Xie; Chaohua Wang
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

4.  Self-expanding metal stents for biliary drainage in patients with resectable pancreatic cancer: single-center experience with 79 cases.

Authors:  Ashwani K Singal; William A Ross; Praveen Guturu; Gauri R Varadhachary; Milind Javle; Sathya R Jaganmohan; Ramu P Raju; Jason B Fleming; Gottumukala S Raju; Yong-Fang Kuo; Jeffrey H Lee
Journal:  Dig Dis Sci       Date:  2011-07-13       Impact factor: 3.199

5.  Comparative costs of metal versus plastic biliary stent strategies for malignant obstructive jaundice by decision analysis.

Authors:  K G Yeoh; M J Zimmerman; J T Cunningham; P B Cotton
Journal:  Gastrointest Endosc       Date:  1999-04       Impact factor: 9.427

6.  Optimum palliation of inoperable hilar cholangiocarcinoma: comparative assessment of the efficacy of plastic and self-expanding metal stents.

Authors:  Ramu P Raju; Sathya R Jaganmohan; William A Ross; Marta L Davila; Milind Javle; Gottumukkala S Raju; Jeffrey H Lee
Journal:  Dig Dis Sci       Date:  2011-01-11       Impact factor: 3.199

7.  Operable malignant jaundice: To stent or not to stent before the operation?

Authors:  Rungsun Rerknimitr; Pinit Kullavanijaya
Journal:  World J Gastrointest Endosc       Date:  2010-01-16

8.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

9.  Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction.

Authors:  P H Davids; A K Groen; E A Rauws; G N Tytgat; K Huibregtse
Journal:  Lancet       Date:  1992 Dec 19-26       Impact factor: 79.321

10.  Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.

Authors:  H Bismuth; M B Corlette
Journal:  Surg Gynecol Obstet       Date:  1975-02
View more
  7 in total

Review 1.  Current status of preoperative biliary drainage.

Authors:  Junko Umeda; Takao Itoi
Journal:  J Gastroenterol       Date:  2015-07-03       Impact factor: 7.527

2.  Locoregional therapies in cholangiocarcinoma.

Authors:  Peter L Labib; Brian R Davidson; Ricky A Sharma; Stephen P Pereira
Journal:  Hepat Oncol       Date:  2017-11-17

Review 3.  Preoperative drainage for malignant biliary strictures: is it time for self-expanding metallic stents?

Authors:  Jason Roque; Shiaw-Hooi Ho; Khean-Lee Goh
Journal:  Clin Endosc       Date:  2015-01-31

4.  Identification of research trends concerning application of stent implantation in the treatment of pancreatic diseases by quantitative and biclustering analysis: a bibliometric analysis.

Authors:  Xuan Zhu; Xing Niu; Tao Li; Chang Liu; Lijie Chen; Guang Tan
Journal:  PeerJ       Date:  2019-10-24       Impact factor: 2.984

5.  Comparison of an Inside Stent and a Fully Covered Self-Expandable Metallic Stent as Preoperative Biliary Drainage for Patients with Resectable Perihilar Cholangiocarcinoma.

Authors:  Hiroshi Mori; Hiroki Kawashima; Eizaburo Ohno; Takuya Ishikawa; Kentaro Yamao; Yasuyuki Mizutani; Tadashi Iida; Masanao Nakamura; Masatoshi Ishigami; Shunsuke Onoe; Takashi Mizuno; Tomoki Ebata; Mitsuhiro Fujishiro
Journal:  Can J Gastroenterol Hepatol       Date:  2022-07-05

Review 6.  Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives.

Authors:  Rocio I R Macias
Journal:  ISRN Hepatol       Date:  2014-02-16

7.  A Retrospective Study of Biliary Drainage Strategies for Patients with Malignant Hilar Biliary Strictures.

Authors:  Xin-Yue Liang; Wen Li; Fang Liu; Xin-Dan Kang
Journal:  Cancer Manag Res       Date:  2021-06-17       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.